Back to top

Image: Bigstock

Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?

Read MoreHide Full Article

Investors focused on the Consumer Staples space have likely heard of MEDIFAST INC (MED - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Staples sector should help us answer this question.

MEDIFAST INC is a member of the Consumer Staples sector. This group includes 177 individual stocks and currently holds a Zacks Sector Rank of #16. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. MED is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past three months, the Zacks Consensus Estimate for MED's full-year earnings has moved 12.31% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

Based on the latest available data, MED has gained about 133.99% so far this year. Meanwhile, the Consumer Staples sector has returned an average of -9.21% on a year-to-date basis. As we can see, MEDIFAST INC is performing better than its sector in the calendar year.

Looking more specifically, MED belongs to the Food - Miscellaneous industry, which includes 42 individual stocks and currently sits at #218 in the Zacks Industry Rank. On average, this group has lost an average of 7.90% so far this year, meaning that MED is performing better in terms of year-to-date returns.

Going forward, investors interested in Consumer Staples stocks should continue to pay close attention to MED as it looks to continue its solid performance.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


MEDIFAST INC (MED) - free report >>